4.6 Article

The role of concurrent chemoradiotherapy in the treatment of locoregionally advanced nasopharyngeal carcinoma among endemic population: a meta-analysis of the phase iii randomized trials

Related references

Note: Only part of the references are listed.
Review Medicine, General & Internal

Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement

David Moher et al.

PLOS MEDICINE (2009)

Article Oncology

Another way to estimate outcome of advanced nasopharyngeal carcinoma - Is concurrent chemoradiotherapy adequate?

JC Lin et al.

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2004)

Article Oncology

Concurrent and adjuvant chemotherapy for nasopharyngeal carcinoma: A factorial study

DLW Kwong et al.

JOURNAL OF CLINICAL ONCOLOGY (2004)

Article Oncology

Concurrent chemotherapy and radiotherapy with low-dose cisplatin for nasopharyngeal carcinoma

T Mizowaki et al.

AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS (2003)

Article Oncology

Concomitant chemoirradiation for stage III-IV nasopharyngeal carcinoma in Chinese patients: Results of a matched cohort analysis

DTT Chua et al.

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2002)

Article Health Care Sciences & Services

Funnel plots for detecting bias in meta-analysis: Guidelines on choice of axis

JAC Sterne et al.

JOURNAL OF CLINICAL EPIDEMIOLOGY (2001)